Fengbei Biotechnology's Shanghai main board IPO has been approved.

On August 7th, the Listing Review Committee of the Shanghai Stock Exchange reviewed the initial public offering of Suzhou Fengbei Biotechnology Co., Ltd., and the company successfully passed the review.